{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-21-007882","form_type":"8-K","ticker":"PMDI","cik":"0000806517","company_name":"PSYCHEMEDICS CORP","filed_at":"2021-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.647431+00:00","generated_at":"2026-06-28T09:36:53.085306+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Psychemedics Q3 revenue up 29% to $6.7M; net income $0.13 EPS vs loss of $0.20","bullets":["Revenue $6.7M vs $5.2M YoY (+29%); domestic revenue up 27% YoY.","Net income of $0.7M ($0.13 diluted EPS) vs net loss of $1.1M (-$0.20).","Employee Retention Credit of $0.8M reduced costs; dividend remains suspended.","Exploration of strategic alternatives continues with JMP Securities; no timetable.","PPP loan of $2.2M fully forgiven by SBA in July 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-21-007882","json":"https://secwatch.observer/filing/0001171843-21-007882.json","markdown":"https://secwatch.observer/filing/0001171843-21-007882.md","text":"https://secwatch.observer/filing/0001171843-21-007882.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/806517/000117184321007882/0001171843-21-007882-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/806517/000117184321007882/f8k_111221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T09:36:53.085306+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}